Medicine | Oncology
Prostate cancer
Overall management
Guidelines, Recommendations


Home > Disciplines > Medicine > Oncology > Prostate cancer > Overall management > Guidelines, Recommendations



General Guidelines


.

Heidelbaugh JJ.
The Adult Well-Male Examination.
Am Fam Physician. 2018 Dec 15;98(12):729-737.
Source | Full text | Similar articles



ACR APPROPRIATENESS CRITERIA


.

Expert Panel on Urologic Imaging:, Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM.
ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.
J Am Coll Radiol. 2018 May;15(5S):S132-S149. doi: 10.1016/j.jacr.2018.03.019.
Source | Full text | Similar articles



AFU



Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mongiat-Artus P, Ploussard G, Mathieu R, Brureau L, Ouzzane A, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Rebillard X, Lebret T, Soulié M, Renard Penna R, Méjean A.
French ccAFU guidelines - Update 2018-2020: Prostate cancer.
Prog Urol. 2018 Nov;28 Suppl 1:R81-R132. doi: 10.1016/j.purol.2019.01.007. Epub 2019 Aug 23. French.
Source . Similar articles



AIOM (Associazione Italiana di Oncologia Medica) GUIDELINES


.

Barra S, Gion M, Introini C, Neumaier C, Sambuceti G, Simonato A, Spina B, Tomasello L
Linee guida. Carcinoma della prostata. Edizione 2016
Associazione Italiana di Oncologia Medica (AIOM).
http://www.aiom.it. (Italian)
Source | Full text



AIRO (Associazione Italiana Radioterapia Oncologica) GUIDELINES


.

Alitto A, Filippo Alongi F, Antognoni P, Arcangeli S, Augurio A, Bellavita R, Bertoni F, Bonetta A, Borghesi S, Bruni A, Buglione M, Cagna E, Cazzaniga LF, Corvò R, D’Agostino G, D’Amico R, D’Angelillo RM, Detti B, De Renzi F, Fabrini MG, Fersino S, Frascino V.
Linee guida Carcinoma della Prostata - AIRO, 2016
Tumori 2016; Special Issue 1: S1-S79. DOI: 10.5301/TJ.2016.15934
. Epub 2016 Jun 23. (Italian)
Source | Full text



AMERICAN JOINT COMMITTEE ON CANCER


.

Buyyounouski MK, Choyke PL, McKenney JK, Sartor O, Sandler HM, Amin MB, Kattan MW, Lin DW.
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
CA Cancer J Clin. 2017 Feb 21. doi: 10.3322/caac.21391. [Epub ahead of print]
Source | Full text | Similar articles



APCCC RECOMMENDATIONS


.

Gillessen S, Fanti S, Omlin A; panelists and authors of APCCC.
Reply to the letter to the editor 'Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al.
Ann Oncol. 2015 Sep 7. pii: mdv360. [Epub ahead of print]
Source | Full text | Similar articles



.

von Eyben F, Kiljunen T, Kangasmaki A, Kairemo K, von Eyben R, Joensuu T.
Management of advanced prostate cancer.
Ann Oncol. 2015 Jul 27. pii: mdv327. [Epub ahead of print]
Source | Full text | Similar articles



.

Gillessen S, Omlin A, Attard G, de Bono JS, Efstathiou E, Fizazi K, Halabi S, Nelson PS, Sartor O, Smith MR, Soule HR, Akaza H, Beer TM, Beltran H, Chinnaiyan AM, Daugaard G, Davis ID, De Santis M, Drake CG, Eeles RA, Fanti S, Gleave ME, Heidenreich A, Hussain M, James ND, Lecouvet FE, Logothetis CJ, Mastris K, Nilsson S, Oh WK, Olmos D, Padhani AR, Parker C, Rubin MA, Schalken JA, Scher HI, Sella A, Shore ND, Small EJ, Sternberg CN, Suzuki H, Sweeney CJ, Tannock IF, Tombal B.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Ann Oncol. 2015 Aug;26(8):1589-604. doi: 10.1093/annonc/mdv257. Epub 2015 Jun 3.
Source | Full text | Similar articles



AUA/ASTRO/SUO GUIDELINES


.

Bekelman JE, Rumble RB, Freedland SJ.
Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an AUA/ASTRO/SUO Guideline Summary.
J Oncol Pract. 2018 Oct;14(10):618-624. doi: 10.1200/JOP.18.00434. Epub 2018 Sep 10.
Source | Full text | Similar articles



.

Bekelman JE, Rumble RB, Chen RC, Pisansky TM, Finelli A, Feifer A, Nguyen PL, Loblaw DA, Tagawa ST, Gillessen S, Morgan TM, Liu G, Vapiwala N, Haluschak JJ, Stephenson A, Touijer K, Kungel T, Freedland SJ.
Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline.
J Clin Oncol. 2018 Sep 5:JCO1800606. doi: 10.1200/JCO.18.00606. [Epub ahead of print]
Source | Full text | Similar articles



.

Cadeddu JA.
Low-Risk Disease: AUA/ASTRO/SUO guideline. (Slides)
Published 2017 May 12-16. American Urological Association website.
Source | Full text



.

Casas F, Oses G, Cortes KS, Barreto TD, Muñoz D.
Ethical commitment of Spanish oncologists to patients with prostate cancer: reflections on the statements of the new ASTRO/AUA guideline (2019 guideline amendment).
Clin Transl Oncol. 2019 Aug 21. doi: 10.1007/s12094-019-02200-0. [Epub ahead of print] No abstract available.
Source | Full text | Similar articles



.

Lowrance WT, Murad MH, Oh WK, Jarrard DF, Resnick MJ, Cookson MS.
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018.
J Urol. 2018 Aug 6. pii: S0022-5347(18)43671-3. doi: 10.1016/j.juro.2018.07.090. [Epub ahead of print]
Source | Full text | Similar articles



.

Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR.
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.
J Urol. 2017 Dec 14. pii: S0022-5347(17)78003-2. doi: 10.1016/j.juro.2017.11.095. [Epub ahead of print]
Source | Full text | Similar articles



.

Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR.
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.
J Urol. 2018 Jan 10. pii: S0022-5347(18)30014-4. doi: 10.1016/j.juro.2018.01.002. [Epub ahead of print]
Source | Full text | Similar articles



.

Sanda MG.
Intermediate-Risk Disease: AUA/ASTRO/SUO guideline. (Slides)
Published 2017 May 12-16. American Urological Association website.
Source | Full text



.

Sanda MG, Chen RC, Crispino T, Freedland S, Greene K, Klotz LH, Makarov DV, Nelson JB, Reston J, Rodrigues G, Sandler HM, Taplin MH, Cadeddu JA.
Clinically localized prostate cancer: AUA/ASTRO/SUO guideline.
Published 2017 Apr. American Urological Association website.
Source | Full text



.

Taplin MH.
High-Risk Disease: AUA/ASTRO/SUO guideline. (Slides)
Published 2017 May 12-16. American Urological Association website.
Source | Full text



CCO GUIDELINES


.

Haider MA, Yao X, Loblaw A, Finelli A.
Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline.
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E1-E7. doi: 10.5489/cuaj.3968.
Source | Full text | Similar articles



CONSENSUS GUIDELINES


.

Egevad L, Samaratunga H, Srigley JR, Delahunt B, Zietman A, Smith J, Klein E, Droller M, Dasgupta P, Catto J.
Consensus guidelines for reporting prostate cancer Gleason Grade.
BJU Int. 2016 Sep;118(3):E1-2. doi: 10.1111/bju.13596.
Source | Full text | Similar articles



.

Horwich A, Hugosson J, de Reijke T, Wiegel T, Fizazi K, Kataja V; Panel Members.
Prostate cancer: ESMO Consensus Conference Guidelines 2012.
Ann Oncol. 2013 May;24(5):1141-62. doi: 10.1093/annonc/mds624. Epub 2013 Jan 9.
Source | Full text | Similar articles



TESTOSTERONE SUPPRESSION


.

Klotz L, Shayegan B, Guillemette C, Collins LL, Gotto G, Guérette D, Jammal MP, Pickles T, Richard PO, Saad F.
Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement.
Can Urol Assoc J. 2018 Feb;12(2):30-37. doi: 10.5489/cuaj.5116. Epub 2017 Dec 19.
Source | Full text | Similar articles



EAU GUIDELINES


.

Mottet N, van den Bergh RCN, Briers E, Bourke L, Cornford P, De Santis M, Gillessen S, Govorov A, Grummet J, Henry AM, Lam TB, Mason MD, van der Poel HG, van der Kwast TH, Rouviere O, Wiegel T, Van den Broeck T, Cumberbatch M, Fossati N, Gross T, Lardas M, Liew M, Moris L, Schoots IG, Willemse PM.
EAU-ESTRO-SIOG Guidelines on Prostate Cancer.
European Association of Urology, Update March 2018.
Source | Full text



.

Mottet N, De Santis M, Briers E, Bourke L, Gillessen S, Grummet JP, Lam TB, van der Poel HG, Rouvière O, van den Bergh RCN, Cornford P.
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.
Eur Urol. 2017 Nov 2. pii: S0302-2838(17)30839-4. doi: 10.1016/j.eururo.2017.09.029. [Epub ahead of print]
Source | Full text | Similar articles



.

Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RC, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P.
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Eur Urol. 2017 Apr;71(4):618-629. doi: 10.1016/j.eururo.2016.08.003. Epub 2016 Aug 25.
Source | Full text | Similar articles



.

Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, Mottet N.
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
Eur Urol. 2017 Apr;71(4):630-642. doi: 10.1016/j.eururo.2016.08.002. Epub 2016 Aug 31.
Source | Full text | Similar articles



.

Mottet N, Bellmunt J, Briers E, Bolla M, Bourke L, Cornford P, De Santis M, Henry AM, Joniau S, Lam TB, Mason MD, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, Arfi N, van den Bergh RCN, Van den Broeck T, Cumberbatch M, Fossati N, Gross T, Lardas M, Liew M, Moldovan P, Schoots IG, Willemsee PM.
EAU-ESTRO-SIOG Guidelines on Prostate Cancer.
European Association of Urology, Update March 2017.
Source | Full text



.

Mottet N, Bellmunt J, Briers E, Bolla M, Cornford P, De Santis M, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, van den Bergh RC, Van den Broeck T, van Casteren NJ, Everaerts W, Marconi L, Moldovan PC
EAU-ESTRO-SIOG Guidelines on Prostate Cancer.
European Association of Urology, Update March 2016.
Source | Full text



.

Mottet N, Bellmunt J, Briers E, van den Bergh RCN, Bolla M, van Casteren NJ,  Cornford P, Culine S, Joniau S, Lam T, Mason MD, Matveev V, van der Poel H, van der Kwast TH, Rouvière O, Wiegel T.
Guidelines on Prostate Cancer.
European Association of Urology. Update March 2015.
Source | Abstract | Full text



.

Sighinolfi MC, Rocco B.
Re: EAU Guidelines: Prostate Cancer 2019.
Eur Urol. 2019 Jul 23. pii: S0302-2838(19)30538-X. doi: 10.1016/j.eururo.2019.07.014. [Epub ahead of print]
Source | Full text | Similar articles



.

Valicenti RK, Thompson I Jr, Albertsen P, Davis BJ, Goldenberg SL, Wolf JS, Sartor O, Klein E, Hahn C, Michalski J, Roach M 3rd, Faraday MM; American Society for Radiation Oncology/American Urological Association.
Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines.
Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):822-8. doi: 10.1016/j.ijrobp.2013.05.029.
Source | Full text | Similar articles



.

Van den Broeck T, van den Bergh RCN, Briers E, Cornford P, Cumberbatch M, Tilki D, De Santis M, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Mason M, Moris L, Schoots IG, van der Kwast T, van der Poel H, Wiegel T, Willemse PM, Rouvière O, Lam TB, Mottet N.
Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations.
Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30159-2. doi: 10.1016/j.euf.2019.06.004. [Epub ahead of print]
Source | Abstract | Similar articles



EAU POSITION PAPER: ACTIVE SURVEILLANCE


.

Briganti A, Fossati N, Catto JWF, Cornford P, Montorsi F, Mottet N, Wirth M, Van Poppel H.
Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018.
Eur Urol. 2018 Jun 21. pii: S0302-2838(18)30433-0. doi: 10.1016/j.eururo.2018.06.008. [Epub ahead of print]
Source | Full text | Similar articles



NCCN GUIDELINES


.

Mason BR, Eastham JA, Davis BJ, Mynderse LA, Pugh TJ, Lee RJ, Ippolito JE.
Current Status of MRI and PET in the NCCN Guidelines for Prostate Cancer.
J Natl Compr Canc Netw. 2019 May 1;17(5):506-513. doi: 10.6004/jnccn.2019.7306.
Source | Full text | Similar articles



.

Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA.
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2019 May 1;17(5):479-505. doi: 10.6004/jnccn.2019.0023.
Source | Full text | Similar articles



.

Mohler JL, Antonarakis ES.
NCCN Guidelines Updates: Management of Prostate Cancer.
J Natl Compr Canc Netw. 2019 May 1;17(5.5):583-586. doi: 10.6004/jnccn.2019.5011.
Source | Full text | Similar articles



.

Mohler JL, Antonarakis ES, Armstrong AJ, Bahnson RR, Clark C, D'Amico AV, Davis BJ, Eastham JA, Ellis R, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Kane CJ, Kuettel M, Lang JM, Lee RJ, Penson DF, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M 3rd, Rosenfeld S, Schaeffer E, Skolarus TA, Small EJ, Sonpavde G, Srinivas S, Strope SA, Tward J, Twardowski P.
Prostate Cancer, Version 2.2017.
Natl Compr Canc Netw. 2017 Feb 21.
Source | Full text



.

Daskivich TJ, Wood L, Skarecky D, Ahlering T, Freedland S.
Limitations of the National Comprehensive Cancer Network Guidelines For Prediction of Limited Life Expectancy in Men with Prostate Cancer.
J Urol. 2016 Aug 28. pii: S0022-5347(16)31192-2. doi: 10.1016/j.juro.2016.08.096. [Epub ahead of print]
Source | Full text | Similar articles



.

Mohler JL, Armstrong AJ, Bahnson RR, D'Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Kane CJ, Kawachi MH, Kuettel M, Lee RJ, Meeks JJ, Penson DF, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M 3rd, Rosenfeld S, Schaeffer E, Skolarus TA, Small EJ, Sonpavde G, Srinivas S, Strope SA, Tward J, Shead DA, Freedman-Cass DA.
Prostate Cancer, Version 1.2016.
J Natl Compr Canc Netw. 2016 Jan;14(1):19-30.
Source | Full text | Similar articles



NICE GUIDELINES


.

NICE guideline
Prostate cancer: diagnosis and management NICE guideline [NG131]. May 2019
National Institute for Health and care Excellence Website. Published 2019 May 9.
Source | Full text



.

[No authors listed]
NICE Guidance - Prostate cancer: diagnosis and management: © NICE (2019) Prostate cancer: diagnosis and management.
BJU Int. 2019 Jul;124(1):9-26. doi: 10.1111/bju.14809. No abstract available. Epub 2019 Jun 17.
Source | Full text | Similar articles



.

Ramaekers BL, Riemsma R, Tomini F, van Asselt T, Deshpande S, Duffy S, Armstrong N, Severens JL, Kleijnen J, Joore MA.
Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
Pharmacoeconomics. 2016 Aug 26. [Epub ahead of print]
Source | Full text | Similar articles



.

Richenberg J.
Can prostate cancer be NICE?
Clin Radiol. 2019 Jul 16. pii: S0009-9260(19)30299-5. doi: 10.1016/j.crad.2019.06.009. [Epub ahead of print]
Source | Full text | Similar articles
Comment on: NICE guideline, Prostate cancer: diagnosis and management NICE guideline [NG131]. May 2019
National Institute for Health and care Excellence Website. Published 2019 May 9.
Source / Full text



PI-RADS STEERING COMMITTEE


.

Padhani AR, Barentsz J, Villeirs G, Rosenkrantz AB, Margolis DJ, Turkbey B, Thoeny HC, Cornud F, Haider MA, Macura KJ, Tempany CM, Verma S, Weinreb JC.
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.
Radiology. 2019 Aug;292(2):464-474. doi: 10.1148/radiol.2019182946. Epub 2019 Jun 11.
Source | Full text | Similar articles



SEOM GUIDELINES


.

Cassinello J, Arranz JÁ, Piulats JM, Sánchez A, Pérez-Valderrama B, Mellado B, Climent MÁ, Olmos D, Carles J, Lázaro M.
SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).
Clin Transl Oncol. 2017 Nov 13. doi: 10.1007/s12094-017-1783-2. [Epub ahead of print]
Source | Full text | Similar articles



.

Grávalos C, Rodríguez C, Sabino A, Seguí MÁ, Virizuela JA, Carmona A, Cassinello J, Isla D, Jara C, Martín M.
SEOM Clinical Guideline for bone metastases from solid tumours (2016).
Clin Transl Oncol. 2016 Dec;18(12):1243-1253. Epub 2016 Nov 28.
Source | Full text | Similar articles



PROSTATE CANCER CLINICAL TRIALS WORKING GROUP




PROGRESSIVE CASTRATION-RESISTANT PROSTATE CANCER


.

Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M; Prostate Cancer Clinical Trials Working Group.
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.
J Clin Oncol. 2008 Mar 1;26(7):1148-59. doi: 10.1200/JCO.2007.12.4487.
Source | Full text | Similar articles



METASTASIS REPORTING AND DATA SYSTEM


.

Padhani AR, Lecouvet FE, Tunariu N, Koh DM, De Keyzer F, Collins DJ, Sala E, Schlemmer HP, Petralia G, Vargas HA, Fanti S, Tombal HB, de Bono J.
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.
Eur Urol. 2016 Jun 14. pii: S0302-2838(16)30241-X. doi: 10.1016/j.eururo.2016.05.033. [Epub ahead of print]
Source | Full text | Similar articles



GUIDELINES FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER


.

Mottet N, De Santis M, Briers E, Bourke L, Gillessen S, Grummet JP, Lam TB, van der Poel HG, Rouvière O, van den Bergh RCN, Cornford P.
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.
Eur Urol. 2017 Nov 2. pii: S0302-2838(17)30839-4. doi: 10.1016/j.eururo.2017.09.029. [Epub ahead of print]
Source | Full text | Similar articles



GUIDELINES FOR CASTRATION-RESISTANT PROSTATE CANCER


.

Foroughi Moghadam MJ, Taheri S, Peiravian F.
A Systematic Review of Clinical Practice Guidelines for Castration-Resistant Prostate Cancer.
Iran J Pharm Res. 2018 Winter;17(Suppl):17-37.
Source | Full text | Similar articles



Specific Guidelines




BIOMARKERS



Eggener SE, Rumble RB, Armstrong AJ, Morgan TM, Crispino T, Cornford P, van der Kwast T, Grignon DJ, Rai AJ, Agarwal N, Klein EA, Den RB, Beltran H.
Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
J Clin Oncol. 2019 Dec 12;JCO1902768. doi: 10.1200/JCO.19.02768. [Epub ahead of print].
Source / Similar articles .



CASTRATION-RESISTANT PROSTATE CANCER


.

Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North S, Pouliot F, Rendon R, Shayegan B, Sridhar S, So A, Usmani N, Vigneault E, Chi KN.
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guidelines for the management of castration-resistant prostate cancer (CRPC).
Can Urol Assoc J. 2019 Jun 25. doi: 10.5489/cuaj.6136. [Epub ahead of print]
Source | Full text | Similar articles



DEFERRED TREATMENT



Lam TBL, MacLennan S, Willemse PM, Mason MD, Plass K, Shepherd R, Baanders R, Bangma CH, Bjartell A, Bossi A, Briers E, Briganti A, Buddingh KT, Catto JWF, Colecchia M, Cox BW, Cumberbatch MG, Davies J, Davis NF, De Santis M, Dell'Oglio P, Deschamps A, Donaldson JF, Egawa S, Fankhauser CD, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Gross T, Grummet JP, Henry AM, Ingels A, Irani J, Lardas M, Liew M, Lin DW, Moris L, Omar MI, Pang KH, Paterson CC, Renard-Penna R, Ribal MJ, Roobol MJ, Rouprêt M, Rouvière O, Sancho Pardo G, Richenberg J, Schoots IG, Sedelaar JPM, Stricker P, Tilki D, Vahr Lauridsen S, van den Bergh RCN, Van den Broeck T, van der Kwast TH, van der Poel HG, van Leenders GJLH, Varma M, Violette PD, Wallis CJD, Wiegel T, Wilkinson K, Zattoni F, N'Dow JMO, Van Poppel H, Cornford P, Mottet N.
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
Eur Urol. 2019 Dec;76(6):790-813. doi: 10.1016/j.eururo.2019.09.020. Epub 2019 Oct 3.
Source . Similar articles



GENETIC TESTING



Mohler JL, Higano CS, Schaeffer EM, Cheng HH.
Current recommendations for prostate cancer genetic testing: NCCN prostate guideline.
Can J Urol. 2019 Oct;26(5S2):34-37.
Source . Similar articles



METASTATIC PROSTATE CANCER


.

Yu EY, Gillessen S, Mottet N.
What Do the Guidelines Say for Metastatic Prostate Cancer Starting Androgen Deprivation Therapy? National Comprehensive Cancer Network, European Society for Medical Oncology, and European Association of Urology recommendations.
Eur Urol Focus. 2018 Oct 1. pii: S2405-4569(18)30287-6. doi: 10.1016/j.euf.2018.09.015. [Epub ahead of print]
Source | Full text | Similar articles



OLIGOMETASTATIC PROSTATE CANCER


.

Lecouvet FE, Oprea-Lager DE, Liu Y, Ost P, Bidaut L, Collette L, Deroose CM, Goffin K, Herrmann K, Hoekstra OS, Kramer G, Lievens Y, Lopci E, Pasquier D, Petersen LJ, Talbot JN, Zacho H, Tombal B, deSouza NM.
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.
Lancet Oncol. 2018 Oct;19(10):e534-e545. doi: 10.1016/S1470-2045(18)30571-0. Epub 2018 Oct 1.
Source | Full text | Similar articles



PROSTATE CANCER GRADING


.

Srigley JR, Delahunt B, Samaratunga H, Billis A, Cheng L, Clouston D, Evans A, Furusato B, Kench J, Leite K, MacLennan G, Moch H, Pan CC, Rioux-Leclercq N, Ro J, Shanks J, Shen S, Tsuzuki T, Varma M, Wheeler T, Yaxley J, Egevad L.
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
Pathology. 2019 Aug;51(5):463-473. doi: 10.1016/j.pathol.2019.05.001. Epub 2019 Jul 3.
Source | Full text | Similar articles



PSA INCREASE AFTER DEFINITIVE TREATMENT


.

Maurer T, Hadaschik B, Budäus L, Steuber T, Salomon G, Horn T, Herrmann K, Weber M, Giesel FL, Berliner C, Eiber M.
[PSA increase after definitive treatment].
Urologe A. 2019 May;58(5):569-582. doi: 10.1007/s00120-019-0931-4. German.
Source | Abstract | Similar articles



SCREENING WITH PSA TEST


.*

Fletcher RH.
Guideline: Experts recommend against prostate cancer screening with prostate-specific antigen test.
Ann Intern Med. 2019 Jan 15;170(2):JC2. doi: 10.7326/ACPJC-2019-170-2-002.
Source | Full text | Similar articles



RADIOTHERAPY



Ghadjar P, Fiorino C, Munck Af Rosenschöld P, Pinkawa M, Zilli T, van der Heide UA.
ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer.
Radiother Oncol. 2019 Dec;141:5-13. doi: 10.1016/j.radonc.2019.08.027. Epub 2019 Oct 23.
Source . Similar articles



.

Lieng H, Hayden AJ, Christie DRH, Davis BJ, Eade TN, Emmett L, Holt T, Hruby G, Pryor D, Shakespeare TP, Sidhom M, Skala M, Wiltshire K, Yaxley J, Kneebone A.
Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group.
Radiother Oncol. 2018 Jul 20. pii: S0167-8140(18)33342-5. doi: 10.1016/j.radonc.2018.06.027. [Epub ahead of print]
Source | Full text | Similar articles



.

Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.
J Urol. 2019 Mar 1;201(3):528-534. doi: 10.1097/JU.0000000000000071.
Source | Full text | Similar articles



.

Morgan SC, Rumble RB, Sandler H.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline Summary.
J Oncol Pract. 2019 Jan;15(1):50-54. doi: 10.1200/JOP.18.00616. Epub 2018 Dec 4.
Source | Full text | Similar articles



.

Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.
J Clin Oncol. 2018 Oct 11:JCO1801097. doi: 10.1200/JCO.18.01097. [Epub ahead of print]
Source | Full text | Similar articles



.

Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.
Pract Radiat Oncol. 2018 Nov - Dec;8(6):354-360. doi: 10.1016/j.prro.2018.08.002. Epub 2018 Oct 11.
Source | Full text | Similar articles



HORMONE THERAPY USE WITH SALVAGE RADIATION THERAPY


.

Spratt DE.
Evidence-based Risk Stratification to Guide Hormone Therapy Use With Salvage Radiation Therapy for Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):556-560. doi: 10.1016/j.ijrobp.2018.06.037.
Source | Full text | Similar articles



SALVAGE RADIOTHERAPY


.

Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O'Meara E, Rosenthal SA, Ritter M, Seider M.
RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):383-7. doi: 10.1016/j.ijrobp.2008.08.002. Epub 2008 Oct 22.
Source | Full text | Similar articles



.

Michalski JM, Lawton C, El Naqa I, Ritter M, O'Meara E, Seider MJ, Lee WR, Rosenthal SA, Pisansky T, Catton C, Valicenti RK, Zietman AL, Bosch WR, Sandler H, Buyyounouski MK, Ménard C.
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):361-8. doi: 10.1016/j.ijrobp.2009.02.006. Epub 2009 Apr 24.
Source | Full text | Similar articles



SCREENING


.

US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, Doubeni CA, Ebell M, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Siu AL, Tseng CW.
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710. Erratum in: JAMA. 2018 Jun 19;319(23):2443.
Source | Full text | Similar articles | Correction



.

Madduri SD.
USPSTF Update of Guidelines on Early Detection of Prostate Cancer.
Mo Med. 2018 Jul-Aug;115(4):337.
Comment on: Grossman DC et al, Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. [JAMA. 2018 May 8].
Source | Full text | Similar articles



.

Tikkinen KAO, Dahm P, Lytvyn L, Heen AF, Vernooij RWM, Siemieniuk RAC, Wheeler R, Vaughan B, Fobuzi AC, Blanker MH, Junod N, Sommer J, Stirnemann J, Yoshimura M, Auer R, MacDonald H, Guyatt G, Vandvik PO, Agoritsas T.
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
BMJ. 2018 Sep 5;362:k3581. doi: 10.1136/bmj.k3581.
Source | Full text | Similar articles



THERANOSTICS


.

Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K.
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging. 2019 Aug 22. doi: 10.1007/s00259-019-04485-3. [Epub ahead of print]
Source | Full text | Similar articles